Application 210526

Type
NDA
Sponsor
TRIS PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DYANAVEL XRAMPHETAMINETABLET, EXTENDED RELEASE;ORAL5MGNoNo
002DYANAVEL XRAMPHETAMINETABLET, EXTENDED RELEASE; ORAL10MGNoNo
003DYANAVEL XRAMPHETAMINETABLET, EXTENDED RELEASE;ORAL15MGNoNo
004DYANAVEL XRAMPHETAMINETABLET, EXTENDED RELEASE; ORAL20MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
24478-106DYANAVEL XRamphetamineNextWave Pharmaceuticals, IncNDACurrent
24478-108DYANAVEL XRamphetamineNextWave Pharmaceuticals, IncNDACurrent
24478-109DYANAVEL XRamphetamineNextWave Pharmaceuticals, IncNDACurrent
24478-110DYANAVEL XRamphetamineNextWave Pharmaceuticals, IncNDACurrent
27808-106DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-106DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-106DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-108DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-108DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-108DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-109DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-109DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-109DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-110DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-110DYANAVEL XRamphetamineTris Pharma IncNDACurrent
27808-110DYANAVEL XRamphetamineTris Pharma IncNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83496SUPPL 2025-09-25
83495SUPPL 2025-09-25
83452SUPPL 2025-09-25
75789SUPPL 2023-10-17
75769SUPPL 2023-10-16
72352SUPPL2022-10-17
71213SUPPL2022-06-06
71204SUPPL2022-06-02
70567ORIG2022-03-21
70380SUPPL2022-03-02
70379SUPPL2022-03-02
70296SUPPL2022-02-28
69271ORIG2021-11-08
69270ORIG2021-11-08
69269ORIG2021-11-08